TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14727 · May 20

#javascript#cloud#cloud_os#cloud_storage#desktop#desktop_environment#dropbox#good_first_issue#gui#javascript#nas#open_source#operating_system#os#osjs#puter#remote_desktop#storage#web_desktop#web_os#webtop Puter is a privacy-first personal cloud that lets you store files, apps, and games securely. You can access everything from anywhere at any time, making it very convenient. It's like a personal computer in the cloud, and you can use it on any device—Windows, Mac, Linux, or even your smartphone. Puter also helps you organize your work and entertainment by allowing multiple virtual desktops. This means you can keep different tasks separate but easily accessible, which helps you work more efficiently. Plus, it's open-source, so you can customize it to fit your needs. https://github.com/HeyPuter/puter

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment